Skip to main content
. 2019 May 2;2019:6201764. doi: 10.1155/2019/6201764

Figure 1.

Figure 1

Comparison of the KMO gene expression in CMTs. (a) KMO gene expression in benign (n = 30) and malignant CMT tissues (n = 54). (b) KMO gene expression in canine malignant CMTs at stages I/II/III (n = 37) and stages IV/V (n = 17). (∗∗∗P < 0.0001).